Profile picture

Doctor Peter Liu

University of Ottawa Heart Institute, Ottawa (Canada)
Membership: HFA Member
Follow
Biography
Dr. Peter Liu is the Chief Scientific Officer and VP of Research of the University of Ottawa Heart Institute, and Professor of Medicine and Physiology at the University of Toronto and Ottawa. He is the former Scientific Director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research, and inaugural Director of the Heart & Stroke/Lewar Centre at University of Toronto. He received his MD from U Toronto, and postgraduate training at Harvard University. His laboratory investigates the causes and treatments of heart failure, role of inflammation and identification of novel biomarkers and targets for intervention in cardiovascular diseases. He has published over 430 peer reviewed articles in high impact journals, and received numerous awards. He has chaired scientific sessions of the Heart Failure Society of America, International Society of Heart Research and Human Proteomic Organization, amongst others.
Logo ESC

Contributor content

Metabolic rewiring in HFpEF
Presentation
Metabolic rewiring in HFpEF
Personalized care of patients with heart failure - REWOLUTION HF international survey on patients' needs and perceptions
Presentation
Personalized care of patients with heart failure - REWOLUTION HF international survey on patients' needs and perceptions
Challenges of integrating omic-derived data.
Presentation
Challenges of integrating omic-derived data.
Practical consideration in the decision-making process.
Presentation
Practical consideration in the decision-making process.
IGFBP-7: a biomarker of senescence.
Presentation
IGFBP-7: a biomarker of senescence.
Current therapies for heart failure: is there room for improvement?
Presentation
Current therapies for heart failure: is there room for improvement?
Earlier is better: the key role of an early intervention in the heart failure patients
Presentation
Earlier is better: the key role of an early intervention in the heart failure patients
Panel discussion about clinical cases - Optimizing the heart failure patients’ pathway right from the discharge.
Presentation
Panel discussion about clinical cases - Optimizing the heart failure patients’ pathway right from the discharge.
Immunosupression: new developments.
Presentation
Immunosupression: new developments.

ESC 365 is supported by